The Digital Pharmaceutical Supply Chain Management Market size was estimated at US$ 0.98 Billion in 2022 it is predicted to grow at a CAGR of 8.23% from 2023 to 2032 to reach around US$ 2.16 Billion by the end of 2032.
The Digital Pharmaceutical Supply Chain Management Market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market
The study offers intricate dynamics about different aspects of the global Digital Pharmaceutical Supply Chain Management Market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global Digital Pharmaceutical Supply Chain Management Market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Bn) and volume (tons).
Sample Link @ https://www.visionresearchreports.com/report/sample/40536
Report Scope of the Digital Pharmaceutical Supply Chain Management Market
| Report Coverage | Details |
| Revenue Share of North America in 2022 | 33% |
| CAGR of Asia Pacific from 2023 to 2032 | 9.58% |
| Revenue Forecast by 2032 | USD 2.16 billion |
| Growth Rate from 2023 to 2032 | CAGR of 8.23% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Companies Covered | McKesson Corporation; Mediceo Corporation; Palantir Technologies, Inc; Jump Technologies, Inc.;InterSystems Corporation;Tecsys; Oracle; SAP; Infor; Terso Solutions; CenTrak (HALMA plc); Biolog-id; TraceLink |
This study covers an elaborate segmentation of the global Digital Pharmaceutical Supply Chain Management Market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global Digital Pharmaceutical Supply Chain Management Market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.
Key Players
McKesson Corporation; Mediceo Corporation; Palantir Technologies, Inc; Jump Technologies, Inc.;InterSystems Corporation;Tecsys; Oracle; SAP; Infor; Terso Solutions; CenTrak (HALMA plc); Biolog-id; TraceLink
Market Segmentation
By Product
- Software
- Hardware
- Services
By Mode Of Delivery
- On-premise
- Cloud-based
- Web-based
By Software Modules
- Planning & Analytics
- Procurement
- Manufacturing
- Logistics
- Inventory Management
By Regional
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Norway
- Sweden
- Denmark
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Research Methodology
The research methodology acquire by analysts for assemble the global Digital Pharmaceutical Supply Chain Management Market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global Digital Pharmaceutical Supply Chain Management Market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Product Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Digital Pharmaceutical Supply Chain Management Market
5.1. COVID-19 Landscape: Digital Pharmaceutical Supply Chain Management Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Digital Pharmaceutical Supply Chain Management Market, By Product
8.1. Digital Pharmaceutical Supply Chain Management Market, by Product, 2023-2032
8.1.1 Software
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Hardware
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Digital Pharmaceutical Supply Chain Management Market, By Mode Of Delivery
9.1. Digital Pharmaceutical Supply Chain Management Market, by Mode Of Delivery, 2023-2032
9.1.1. On-premise
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Cloud-based
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Web-based
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Digital Pharmaceutical Supply Chain Management Market, By Software
10.1. Digital Pharmaceutical Supply Chain Management Market, by Software, 2023-2032
10.1.1. Planning & Analytics
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Procurement
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Manufacturing
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Logistics
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Inventory Management
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Digital Pharmaceutical Supply Chain Management Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.1.3. Market Revenue and Forecast, by Software (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.1.4.3. Market Revenue and Forecast, by Software (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.1.5.3. Market Revenue and Forecast, by Software (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.2.3. Market Revenue and Forecast, by Software (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.2.4.3. Market Revenue and Forecast, by Software (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.2.5.3. Market Revenue and Forecast, by Software (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.2.6.3. Market Revenue and Forecast, by Software (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.2.7.3. Market Revenue and Forecast, by Software (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.3.3. Market Revenue and Forecast, by Software (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.3.4.3. Market Revenue and Forecast, by Software (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.3.5.3. Market Revenue and Forecast, by Software (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.3.6.3. Market Revenue and Forecast, by Software (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.3.7.3. Market Revenue and Forecast, by Software (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.4.3. Market Revenue and Forecast, by Software (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.4.4.3. Market Revenue and Forecast, by Software (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.4.5.3. Market Revenue and Forecast, by Software (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.4.6.3. Market Revenue and Forecast, by Software (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.4.7.3. Market Revenue and Forecast, by Software (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.5.3. Market Revenue and Forecast, by Software (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.5.4.3. Market Revenue and Forecast, by Software (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Mode Of Delivery (2020-2032)
11.5.5.3. Market Revenue and Forecast, by Software (2020-2032)
Chapter 12. Company Profiles
12.1. McKesson Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Mediceo Corporation.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Palantir Technologies, Inc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Jump Technologies, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. InterSystems Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Tecsys
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Oracle.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. SAP
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Infor.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Terso Solutions
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Vision Research Reports
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168